478 related articles for article (PubMed ID: 31733631)
1. Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects.
Holze F; Vizeli P; Müller F; Ley L; Duerig R; Varghese N; Eckert A; Borgwardt S; Liechti ME
Neuropsychopharmacology; 2020 Feb; 45(3):462-471. PubMed ID: 31733631
[TBL] [Abstract][Full Text] [Related]
2. Acute subjective effects in LSD- and MDMA-assisted psychotherapy.
Schmid Y; Gasser P; Oehen P; Liechti ME
J Psychopharmacol; 2021 Apr; 35(4):362-374. PubMed ID: 33853422
[TBL] [Abstract][Full Text] [Related]
3. Alterations of consciousness and mystical-type experiences after acute LSD in humans.
Liechti ME; Dolder PC; Schmid Y
Psychopharmacology (Berl); 2017 May; 234(9-10):1499-1510. PubMed ID: 27714429
[TBL] [Abstract][Full Text] [Related]
4. Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants.
Straumann I; Ley L; Holze F; Becker AM; Klaiber A; Wey K; Duthaler U; Varghese N; Eckert A; Liechti ME
Neuropsychopharmacology; 2023 Dec; 48(13):1840-1848. PubMed ID: 37258715
[TBL] [Abstract][Full Text] [Related]
5. Characterizing Thalamocortical (Dys)connectivity Following D-Amphetamine, LSD, and MDMA Administration.
Avram M; Müller F; Rogg H; Korda A; Andreou C; Holze F; Vizeli P; Ley L; Liechti ME; Borgwardt S
Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Sep; 7(9):885-894. PubMed ID: 35500840
[TBL] [Abstract][Full Text] [Related]
6. Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects.
Dolder PC; Müller F; Schmid Y; Borgwardt SJ; Liechti ME
Psychopharmacology (Berl); 2018 Feb; 235(2):467-479. PubMed ID: 28551715
[TBL] [Abstract][Full Text] [Related]
7. Long-lasting subjective effects of LSD in normal subjects.
Schmid Y; Liechti ME
Psychopharmacology (Berl); 2018 Feb; 235(2):535-545. PubMed ID: 28918441
[TBL] [Abstract][Full Text] [Related]
8. Effective Connectivity of Thalamocortical Interactions Following d-Amphetamine, LSD, and MDMA Administration.
Avram M; Müller F; Preller KH; Razi A; Rogg H; Korda A; Holze F; Vizeli P; Ley L; Liechti ME; Borgwardt S
Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 May; 9(5):522-532. PubMed ID: 37532129
[TBL] [Abstract][Full Text] [Related]
9. Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects.
Schmid Y; Enzler F; Gasser P; Grouzmann E; Preller KH; Vollenweider FX; Brenneisen R; Müller F; Borgwardt S; Liechti ME
Biol Psychiatry; 2015 Oct; 78(8):544-53. PubMed ID: 25575620
[TBL] [Abstract][Full Text] [Related]
10. Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.
Holze F; Ley L; Müller F; Becker AM; Straumann I; Vizeli P; Kuehne SS; Roder MA; Duthaler U; Kolaczynska KE; Varghese N; Eckert A; Liechti ME
Neuropsychopharmacology; 2022 May; 47(6):1180-1187. PubMed ID: 35217796
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.
Dolder PC; Schmid Y; Steuer AE; Kraemer T; Rentsch KM; Hammann F; Liechti ME
Clin Pharmacokinet; 2017 Oct; 56(10):1219-1230. PubMed ID: 28197931
[TBL] [Abstract][Full Text] [Related]
12. Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study.
Hutten NRPW; Mason NL; Dolder PC; Theunissen EL; Holze F; Liechti ME; Feilding A; Ramaekers JG; Kuypers KPC
Eur Neuropsychopharmacol; 2020 Dec; 41():81-91. PubMed ID: 33082016
[TBL] [Abstract][Full Text] [Related]
13. Reinforcement schedule effects in rats trained to discriminate 3,4-methylenedioxymethamphetamine (MDMA) or cocaine.
Kueh D; Baker LE
Psychopharmacology (Berl); 2007 Jan; 189(4):447-57. PubMed ID: 17019568
[TBL] [Abstract][Full Text] [Related]
14. Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.
Ley L; Holze F; Arikci D; Becker AM; Straumann I; Klaiber A; Coviello F; Dierbach S; Thomann J; Duthaler U; Luethi D; Varghese N; Eckert A; Liechti ME
Neuropsychopharmacology; 2023 Oct; 48(11):1659-1667. PubMed ID: 37231080
[TBL] [Abstract][Full Text] [Related]
15. Effects of lisdexamfetamine on plasma steroid concentrations compared with d-amphetamine in healthy subjects: A randomized, double-blind, placebo-controlled study.
Strajhar P; Vizeli P; Patt M; Dolder PC; Kratschmar DV; Liechti ME; Odermatt A
J Steroid Biochem Mol Biol; 2019 Feb; 186():212-225. PubMed ID: 30381248
[TBL] [Abstract][Full Text] [Related]
16. Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers.
Bershad AK; Schepers ST; Bremmer MP; Lee R; de Wit H
Biol Psychiatry; 2019 Nov; 86(10):792-800. PubMed ID: 31331617
[TBL] [Abstract][Full Text] [Related]
17. Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects.
Holze F; Vizeli P; Ley L; Müller F; Dolder P; Stocker M; Duthaler U; Varghese N; Eckert A; Borgwardt S; Liechti ME
Neuropsychopharmacology; 2021 Feb; 46(3):537-544. PubMed ID: 33059356
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants.
Holze F; Liechti ME; Hutten NRPW; Mason NL; Dolder PC; Theunissen EL; Duthaler U; Feilding A; Ramaekers JG; Kuypers KPC
Clin Pharmacol Ther; 2021 Mar; 109(3):658-666. PubMed ID: 32975835
[TBL] [Abstract][Full Text] [Related]
19. The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial.
Yanakieva S; Polychroni N; Family N; Williams LTJ; Luke DP; Terhune DB
Psychopharmacology (Berl); 2019 Apr; 236(4):1159-1170. PubMed ID: 30478716
[TBL] [Abstract][Full Text] [Related]
20. 'Candyflipping': synergistic discriminative effect of LSD and MDMA.
Schechter MD
Eur J Pharmacol; 1998 Jan; 341(2-3):131-4. PubMed ID: 9543229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
